Aethlon Medical, Inc. is a pioneering medical device company dedicated to addressing life-threatening conditions through innovative technologies, despite facing financial challenges in the health care sector.

Aethlon Medical, Inc. is a pioneering force in medical device technology, dedicated to revolutionizing the treatment of life-threatening conditions through innovative solutions for cancer and infectious diseases.

Aethlon Medical, a medical device company, is set to release its quarterly earnings on June 26, 2025, with analysts expecting a loss of $1.073 per share for the quarter.